An anorexic lipid mediator regulated by feeding

被引:521
作者
de Fonseca, FR
Navarro, M
Gómez, R
Escuredo, L
Nava, F
Fu, J
Murillo-Rodríguez, E
Giuffrida, A
LoVerme, J
Gaetani, S
Kathuria, S
Gall, C
Piomelli, D [1 ]
机构
[1] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA
[2] Univ Complutense, Dept Psychobiol, Madrid 28233, Spain
[3] Fdn Hosp Carlos Haya, Malaga 29010, Spain
[4] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA
关键词
D O I
10.1038/35102582
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Oleylethanolamide (OEA) is a natural analogue of the endogenous cannabinoid anandamide. Like anandamide, OEA is produced in cells in a stimulus-dependent manner and is rapidly eliminated by enzymatic hydrolysis, suggesting a function in cellular signalling(1). However, OEA does not activate cannabinoid receptors and its biological functions are still unknown(2). Here we show that, in rats, food deprivation markedly reduces OEA biosynthesis in the small intestine. Administration of OEA causes a potent and persistent decrease in food intake and gain in body mass. This anorexic effect is behaviourally selective and is associated with the discrete activation of brain regions (the paraventricular hypothalamic nucleus and the nucleus of the solitary tract) involved in the control of satiety. OEA does not affect food intake when injected into the brain ventricles, and its anorexic actions are prevented when peripheral sensory fibres are removed by treatment with capsaicin. These results indicate that OEA is a lipid mediator involved in the peripheral regulation of feeding.
引用
收藏
页码:209 / 212
页数:4
相关论文
共 29 条
  • [21] Navarro M, 1996, J NEUROCHEM, V67, P1982
  • [22] Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat
    Navarro, M
    Hernandez, E
    Munoz, RM
    delArco, I
    Villanua, MA
    Carrera, MRA
    deFonseca, FR
    [J]. NEUROREPORT, 1997, 8 (02) : 491 - 496
  • [23] Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development
    Pertwee, RG
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (07) : 1553 - 1571
  • [24] Endogenous cannabinoid signaling
    Piomelli, D
    Beltramo, M
    Giuffrida, A
    Stella, N
    [J]. NEUROBIOLOGY OF DISEASE, 1998, 5 (06) : 462 - 473
  • [25] Cholecystokinin: proofs and prospects for involvement in control of food intake and body weight
    Ritter, RC
    Covasa, M
    Matson, CA
    [J]. NEUROPEPTIDES, 1999, 33 (05) : 387 - 399
  • [26] The N-acylation-phosphodiesterase pathway and cell signalling
    Schmid, HHO
    Schmid, PC
    Natarajan, V
    [J]. CHEMISTRY AND PHYSICS OF LIPIDS, 1996, 80 (1-2) : 133 - 142
  • [27] SCHMID PC, 1985, J BIOL CHEM, V260, P4145
  • [28] Central nervous system control of food intake
    Schwartz, MW
    Woods, SC
    Porte, D
    Seeley, RJ
    Baskin, DG
    [J]. NATURE, 2000, 404 (6778) : 661 - 671
  • [29] WILLIAMS SK, 1999, TIS ENGN INTELL UNIT, V1, P143